Your browser doesn't support javascript.
loading
Prototype and BA.5 protein nanoparticle vaccines protect against Omicron BA.5 variant in Syrian hamsters.
Bricker, Traci L; Joshi, Astha; Soudani, Nadia; Scheaffer, Suzanne M; Patel, Nita; Guebre-Xabier, Mimi; Smith, Gale; Diamond, Michael S; Boon, Adrianus C M.
Affiliation
  • Bricker TL; Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
  • Joshi A; Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
  • Soudani N; Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
  • Scheaffer SM; Department of Pathology and Immunology, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
  • Patel N; Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
  • Guebre-Xabier M; Novavax Inc., Gaithersburg, Maryland, USA.
  • Smith G; Novavax Inc., Gaithersburg, Maryland, USA.
  • Diamond MS; Novavax Inc., Gaithersburg, Maryland, USA.
  • Boon ACM; Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
J Virol ; 98(3): e0120623, 2024 Mar 19.
Article in En | MEDLINE | ID: mdl-38305154

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Vaccines / SARS-CoV-2 / Nanovaccines Limits: Animals Language: En Journal: J Virol Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Vaccines / SARS-CoV-2 / Nanovaccines Limits: Animals Language: En Journal: J Virol Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos